Target intelligence / Profile preview

Bacterial surface receptors of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii

Molecular classification
Receptor, Adhesin, Outer membrane protein, Lectin, Pilus protein
01

Overview

Bacterial surface receptors on Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii are a diverse set of proteins and glycans that facilitate the initial stages of infection, including colonization and biofilm formation. In S. aureus, these include Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) like Clumping factor A (ClfA) and Protein A (Spa), which are vital for binding host extracellular matrix proteins and evading immune detection (Foster et al., 2014, PMID: 24413161). P. aeruginosa and A. baumannii utilize surface structures such as Type IV pili, lectins (LecA/B), and outer membrane proteins (e.g., OmpA) to adhere to host cells and environmental surfaces, contributing to their persistence in clinical settings (Giraud & de Bentzmann, 2012, PMID: 22460523; Lee et al., 2017, PMID: 28163631). These receptors are primary targets for anti-virulence therapies, including monoclonal antibodies like Tefibazumab and MEDI3902, which aim to block bacterial attachment or promote clearance by the immune system (DiGiandomenico et al., 2014, PMID: 25393894). By targeting these surface-exposed molecules, researchers hope to develop treatments that reduce the severity of infections such as pneumonia and sepsis while minimizing the selective pressure that drives antibiotic resistance.

Other names
Bacterial adhesinsMicrobial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs)Surface-exposed virulence factorsCell wall-anchored proteins
02

Mechanism of action

Inhibition of bacterial adhesion to host tissues, neutralization of surface-associated virulence factors, and enhancement of opsonophagocytic killing by the host immune system.

03

Biological functions

Cell adhesionBiofilm formationImmune evasionHost-cell invasionVirulence
04

Disease associations

InfectionSepsisPneumoniaBacteremiaSkin and soft tissue infection
05

Safety considerations

Antigenic variation leading to immune escapeHigh species specificity limiting broad-spectrum usePotential for off-target effects on commensal microbiotaRisk of antibody-dependent enhancement (ADE)
06

Interacting drugs

Tefibazumab

4 more in the full profile.

07

Biomarkers

Bacterial surface protein expressionSerum procalcitoninC-reactive proteinPathogen-specific antibody titers

Beyond the preview

Go deeper on Bacterial surface receptors of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial surface receptors of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call